11/03/2026
There have been several exciting and important developments in pancreatic cancer research within the last few years.
Pancreatic cancer, predominantly manifesting as pancreatic ductal adenocarcinoma (PDAC), is a highly aggressive malignancy characterized by late-stage diagnosis and poor prognosis.
Most patients present with advanced disease, where surgical options are limited. Therefore, these new advances in pancreatic cancer research are critical and promising.
To learn more about these new scientific advances, visit our pancreatic cancer page on our website:
👉canceredinstitute.org/pancreatic-cancer
🌍🎗️ Join our global ™ campaign and learn how to get your shirt to support personalized cancer care:
👉canceredinstitute.org/shop-at-ceri
Follow us:
👉Sign up for our free e-newsletter: canceredinstitute.org
✅ If you have any specific questions and need help related to your specific situation and would like us to look into it, please fill out our online form on our website: canceredinstitute.org/patient-program
✅ Please donate to support our education and research programs: canceredinstitute.org/donate